These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26064880)

  • 1. Morphine Promotes Tumor Angiogenesis and Increases Breast Cancer Progression.
    Bimonte S; Barbieri A; Rea D; Palma G; Luciano A; Cuomo A; Arra C; Izzo F
    Biomed Res Int; 2015; 2015():161508. PubMed ID: 26064880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancer.
    Bimonte S; Barbieri A; Palma G; Rea D; Luciano A; D'Aiuto M; Arra C; Izzo F
    Biomed Res Int; 2015; 2015():878134. PubMed ID: 25879038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone Counteracts the Promoting Tumor Growth Effects Induced by Morphine in an Animal Model of Triple-negative Breast Cancer.
    Bimonte S; Barbieri A; Cascella M; Rea D; Palma G; Luciano A; Forte CA; Cuomo A; Arra C
    In Vivo; 2019; 33(3):821-825. PubMed ID: 31028203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
    Seitz S; Rick FG; Schally AV; Treszl A; Hohla F; Szalontay L; Zarandi M; Ortmann O; Engel JB; Buchholz S
    Oncol Rep; 2013 Jul; 30(1):413-8. PubMed ID: 23624870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer.
    Zhang QQ; Chen J; Zhou DL; Duan YF; Qi CL; Li JC; He XD; Zhang M; Yang YX; Wang L
    Int J Biol Sci; 2017; 13(4):471-479. PubMed ID: 28529455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative administration of ketorolac averts morphine-induced angiogenesis and metastasis in triple-negative breast cancer.
    Liu Z; Cheng S; Fu G; Ji F; Wang C; Cao M
    Life Sci; 2020 Jun; 251():117604. PubMed ID: 32243929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer.
    Li QW; Zhang GL; Hao CX; Ma YF; Sun X; Zhang Y; Cao KX; Li BX; Yang GW; Wang XM
    J Ethnopharmacol; 2021 Feb; 266():113430. PubMed ID: 33011366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Copper Transport Induces Apoptosis in Triple-Negative Breast Cancer Cells and Suppresses Tumor Angiogenesis.
    Karginova O; Weekley CM; Raoul A; Alsayed A; Wu T; Lee SS; He C; Olopade OI
    Mol Cancer Ther; 2019 May; 18(5):873-885. PubMed ID: 30824611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fucoidan from Laminaria japonica exerts antitumor effects on angiogenesis and micrometastasis in triple-negative breast cancer cells.
    Hsu WJ; Lin MH; Kuo TC; Chou CM; Mi FL; Cheng CH; Lin CW
    Int J Biol Macromol; 2020 Apr; 149():600-608. PubMed ID: 32004612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125.
    Seitz S; Buchholz S; Schally AV; Weber F; Klinkhammer-Schalke M; Inwald EC; Perez R; Rick FG; Szalontay L; Hohla F; Segerer S; Kwok CW; Ortmann O; Engel JB
    BMC Cancer; 2014 Nov; 14():847. PubMed ID: 25410881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
    Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
    Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
    Thoennissen NH; O'Kelly J; Lu D; Iwanski GB; La DT; Abbassi S; Leiter A; Karlan B; Mehta R; Koeffler HP
    Oncogene; 2010 Jan; 29(2):285-96. PubMed ID: 19855437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperine enhances the efficacy of TRAIL-based therapy for triple-negative breast cancer cells.
    Abdelhamed S; Yokoyama S; Refaat A; Ogura K; Yagita H; Awale S; Saiki I
    Anticancer Res; 2014 Apr; 34(4):1893-9. PubMed ID: 24692724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terrestrosin D, a steroidal saponin from Tribulus terrestris L., inhibits growth and angiogenesis of human prostate cancer in vitro and in vivo.
    Wei S; Fukuhara H; Chen G; Kawada C; Kurabayashi A; Furihata M; Inoue K; Shuin T
    Pathobiology; 2014; 81(3):123-32. PubMed ID: 24642631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer.
    Jang NY; Kim DH; Cho BJ; Choi EJ; Lee JS; Wu HG; Chie EK; Kim IA
    BMC Cancer; 2015 Mar; 15():89. PubMed ID: 25884663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A soluble form of GAS1 inhibits tumor growth and angiogenesis in a triple negative breast cancer model.
    Jiménez A; López-Ornelas A; Estudillo E; González-Mariscal L; González RO; Segovia J
    Exp Cell Res; 2014 Oct; 327(2):307-17. PubMed ID: 24992044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of structure-based small molecular inhibitor of αB-crystallin against basal-like/triple-negative breast cancer development in vitro and in vivo.
    Chen Z; Ruan Q; Han S; Xi L; Jiang W; Jiang H; Ostrov DA; Cai J
    Breast Cancer Res Treat; 2014 May; 145(1):45-59. PubMed ID: 24710637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral expression of mature human neutrophil peptide-1 potentiates the therapeutic effect of doxorubicin in a mouse 4T1 breast cancer model.
    Li D; Qin Q; Wang XY; Shi HS; Luo M; Guo FC; Wang W; Wang YS
    Oncol Rep; 2014 Mar; 31(3):1287-95. PubMed ID: 24378474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cell survival, cell cycle progression, tumor growth and cyclooxygenase-2 activity in MDA-MB-231 breast cancer cells by camphorataimide B.
    Lin WL; Lee YJ; Wang SM; Huang PY; Tseng TH
    Eur J Pharmacol; 2012 Apr; 680(1-3):8-15. PubMed ID: 22329896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.